| Name | Sarmentosin |
|---|---|
| Synonyms |
(2E)-4-(β-D-Glucopyranosyloxy)-2-(hydroxymethyl)-2-butenenitrile
2-Butenenitrile, 4-(β-D-glucopyranosyloxy)-2-(hydroxymethyl)-, (2E)- 2-Butenenitrile, 4-(β-D-glucopyranosyloxy)-2-(hydroxymethyl)-, (E)- |
| Description | Sarmentosin is an activator of Nrf2. Sarmentosin inhibits mTOR signaling and induces autophagy-dependent apoptosis in human HCC cells[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 621.9±55.0 °C at 760 mmHg |
| Molecular Formula | C11H17NO7 |
| Molecular Weight | 275.26 |
| Flash Point | 329.9±31.5 °C |
| Exact Mass | 275.100494 |
| PSA | 143.40000 |
| LogP | -2.43 |
| Vapour Pressure | 0.0±4.1 mmHg at 25°C |
| Index of Refraction | 1.593 |
| Hazard Codes | Xi |
|---|